Applied DNA Sciences (NASDAQ:APDN) 公布的季度每股亏损为$(0.32)，比分析师普遍预期的$(0.34)高出5.88%。公司报告的季度销售额为$813.11千，低于分析师普遍预期的$899.00千，低9.55%。这比去年同期的$779.74千增长了4.28%。
以上内容来自Benzinga Earnings专栏，原文如下：
Applied DNA Sciences (NASDAQ:APDN) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.34) by 5.88 percent. The company reported quarterly sales of $813.11 thousand which missed the analyst consensus estimate of $899.00 thousand by 9.55 percent. This is a 4.28 percent increase over sales of $779.74 thousand the same period last year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.